I.G. Investment Management’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-14,200
Closed -$3.45M 504
2017
Q2
$3.45M Buy
14,200
+2,000
+16% +$470K 0.02% 230
2017
Q1
$2.92M Sell
12,200
-2,300
-16% -$536K 0.01% 238
2016
Q4
$3.04M Sell
14,500
-63,833
-81% -$13.2M 0.02% 240
2016
Q3
$18M Buy
78,333
+12,014
+18% +$2.94M 0.07% 173
2016
Q2
$15.3M Sell
66,319
-13,448
-17% -$3.1M 0.06% 184
2016
Q1
$21.4M Sell
79,767
-43,237
-35% -$12.4M 0.09% 143
2015
Q4
$38.4M Buy
123,004
+5,956
+5% +$1.77M 0.16% 90
2015
Q3
$31.8M Buy
+117,048
New +$36M 0.13% 100
2015
Q2
Sell
-175,538
Closed -$52.2M 917
2015
Q1
$52.2M Sell
175,538
-20,469
-10% -$5.84M 0.2% 84
2014
Q4
$50.5M Buy
196,007
+8,749
+5% +$2.19M 0.18% 81
2014
Q3
$45.2M Buy
187,258
+27,642
+17% +$6.19M 0.16% 90
2014
Q2
$35.6M Buy
159,616
+45,718
+40% +$9.47M 0.12% 105
2014
Q1
$23.4M Sell
113,898
-30,451
-21% -$6.03M 0.08% 140
2013
Q4
$24.3M Buy
144,349
+886
+0.6% +$139K 0.09% 131
2013
Q3
$20.7M Sell
143,463
-4,970
-3% -$662K 0.08% 145
2013
Q2
$18.7M Buy
+148,433
New +$16.8M 0.08% 147

Other funds holding AGN

I.G. Investment Management's AGN Position: Q3 2017 in Review

I.G. Investment Management sold out of Allergan plc (AGN) in Q3 2017, closing a stake of 14,200 shares — an estimated $3.45M sold.

I.G. Investment Management first reported a position in AGN in Q2 2013 and held it in 16 quarters. The position peaked at $52.2M in Q1 2015. 1,090 funds tracked by Wall St. Rank hold AGN as of Q3 2017.

  • I.G. Investment Management reported no remaining Allergan plc position as of Q3 2017 after selling out during the quarter.
  • I.G. Investment Management sold 14,200 Allergan plc shares in Q3 2017, an estimated $3.45M.
  • I.G. Investment Management first reported a position in Allergan plc in Q2 2013 and held it in 16 quarters.
  • I.G. Investment Management's Allergan plc position peaked at $52.2M in Q1 2015.
  • 1,090 funds tracked by Wall St. Rank held Allergan plc as of Q3 2017.

Based on I.G. Investment Management's 13F filing for Q3 2017, filed 14 Nov 2017.